Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms.
about
Immunopathogenesis and therapy of cutaneous T cell lymphoma.Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)Treatment of cutaneous T-cell lymphoma with retinoids.Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma.Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.New targets of therapy in T-cell lymphomas.U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.Juvenile mycosis fungoides treated with bexarotene and PUVA.Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
P2860
Q33726963-356C5E57-EBDC-4909-B6E5-4697FC702709Q35022833-C15FA44D-E695-4559-8DE0-4C31E6DE85E0Q36609811-4E88F78A-6AF9-41FC-9513-478B778D5A56Q36844207-BC660413-AB33-4AF0-A14D-69DBE51C6D1CQ36868770-83E36081-CAFA-4A27-B43B-04BF8150BDF3Q37701472-BECDAB5E-7B56-4B3A-BBD5-076B2655242FQ38042090-F74A3E2F-E27C-482A-9BA2-3E1FFB53385DQ40460435-A6F6099E-861B-4CB3-8D8C-EB51B23900E2Q45928991-E9B2CD5D-F34E-42F8-B2B2-D7A8926CB57B
P2860
Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Low-dose oral bexarotene in co ...... ssible immunologic mechanisms.
@ast
Low-dose oral bexarotene in co ...... ssible immunologic mechanisms.
@en
type
label
Low-dose oral bexarotene in co ...... ssible immunologic mechanisms.
@ast
Low-dose oral bexarotene in co ...... ssible immunologic mechanisms.
@en
prefLabel
Low-dose oral bexarotene in co ...... ssible immunologic mechanisms.
@ast
Low-dose oral bexarotene in co ...... ssible immunologic mechanisms.
@en
P2093
P1476
Low-dose oral bexarotene in co ...... ssible immunologic mechanisms.
@en
P2093
Alain H Rook
Carmela C Vittorio
Glen Crawford
Jacqueline M Junkins-Hopkins
Karen S McGinnis
Michael Shapiro
P304
P356
10.1016/J.JAAD.2003.10.669
P407
P577
2004-03-01T00:00:00Z